THTX: Rega marang dodolan Theratechnologies, Inc
Theratechnologies Inc. management is currently optimizing expenses to achieve stable profitability. This price-to-sales chart helps assess the asset's valuation dynamics, where 1.80 reflects the metric's latest value. The business relies on exclusive medications for treating endocrine disorders and HIV. Manufacturing capacities in North America ensure the production of niche drugs and the development of oncology therapies.
Rincian metrik lan analitis perusahaan Theratechnologies Inc (THTX)
- rega saham lan target rega konsensus:
- informasi kapitalisasi pasar:
- data nilai buku modal saham:
- rincian struktur utang lan likuiditas bisnis:
Utang marang Modal Theratechnologies Inc.|THTX - Utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal Theratechnologies, Inc|THTX - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Theratechnologies Inc|THTX - Kewajiban jangka dawa perusahaan|Gedhene kewajiban jangka cendhak Theratechnologies|Likuiditas darurat theratech.com
- statistik bathi lan rasio pasar:
THTX - Bathi resik|Bathi mangsa ngarep Theratechnologies Inc.|THTX - Pangali P/E|Pangali mangsa ngarep rega marang bathi Theratechnologies, Inc.|THTX - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi operasional sadurunge panyusutan Theratechnologies Inc|THTX - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben siji saham sajrone rolas wulan pungkasan Theratechnologies|THTX - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan theratech.com|THTX - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep Theratechnologies Inc.
- rincian pendapatan lan dodolan emiten:
Analisis umum perusahaan:THTX theratech.com
When constructing a long-term portfolio, utilizing fundamental screening to identify undervalued assets is critically important. This price-to-sales multiple compares the market value of Theratechnologies Inc. (THTX) with its annual sales volume, allowing for an assessment of how effectively the company monetizes its monopoly position in HIV therapy through an analysis of this chart.
Karo sapa Theratechnologies Inc. saingan
argenx.com - Rasio kapitalisasi marang pendapatan|Multiplikator P/S BNTX (BioNTech)|Abivax Pharma (ABVX) - Rega marang dodolan|ADMA: Kapitalisasi marang pendapatan|Protagonist Corp - Kapitalisasi marang volume dodolan|IMVT: Multiplikator P/S|kiniksa.com - Rasio kapitalisasi pasar marang pendapatan|GRFS (Grifols) - Multiplikator P/S|Rega marang dodolan Adaptive Biotech ADPT|Rasio rega marang pendapatan Celldex (CLDX)|AUPH (Aurinia Corp) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S BCRX (BioCryst)|Multiplikator P/S veratx.com VERA|DNTH: Kapitalisasi marang pendapatan|Pharvaris NV - Kapitalisasi marang volume dodolan|ABCL: Multiplikator P/S|Rega marang dodolan Tourmaline (TRML)|PGEN (Precigen, Inc.) - Multiplikator P/S|Kapitalisasi marang pendapatan pharming.com (PHAR)|Multiplikator P/S NKTR|UPB (Upstream Bio, Inc.) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Zenas Biopharma, Inc. ZBIO|IMNM: Rasio kapitalisasi marang pendapatan|GOSS - Rasio rega marang pendapatan|Rega marang dodolan kalvista.com|Septerna (SEPN) - Rasio rega marang pendapatan|PVLA (Pieris Pharma) - Rasio rega marang pendapatan|Rasio rega marang pendapatan Savara Corp|Rega marang dodolan Rigel Corp RIGL|Multiplikator P/S ANAB|astriatx.com (ATXS) - Multiplikator rega marang pendapatan|Multiplikator P/S ENGN (enGene)|Koefisien rega marang pendapatan RAPT Therapeutics Inc. (RAPT)|Aerovate - Multiplikator P/S|Rega marang dodolan Aclaris Therapeutics, Inc|Kyverna Therapeutics (KYTX) - Rasio rega marang pendapatan|TLSA - Koefisien rega marang pendapatan|Kapitalisasi marang pendapatan CABA|VTYX: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S AVTX|Koefisien rega marang pendapatan Eledon Pharmaceuticals, Inc|Rasio rega marang pendapatan Agenus AGEN|CLYM: Rasio kapitalisasi marang pendapatan|Zura Bio - Multiplikator P/S|aTyr Pharma Inc (ATYR) - Kapitalisasi marang pendapatan|ADAG (adagene.com) - Kapitalisasi marang pendapatan|IMA - Koefisien rega marang pendapatan|Kapitalisasi marang pendapatan STTK|EQ (Equillium Bio) - Kapitalisasi marang volume dodolan|Multiplikator P/S CNTB|IMUX (immunic-therapeutics.com) - Rasio kapitalisasi pasar marang pendapatan|Atara Bio - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan IFRX (InflaRx NV)|XFOR: Kapitalisasi marang pendapatan|ACET (Adicet Bio) - Rasio kapitalisasi marang pendapatan|celularity.com (CELU) - Rasio rega marang pendapatan|Rasio rega marang dodolan INMB (INmune Bio Inc)|BRNS (Barinthus Bio) - Multiplikator P/S|KZR: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S SABS|Multiplikator P/S akaritx.com (AKTX)|Rasio rega marang pendapatan Enlivex Therapeutics Ltd. ENLV|Rasio kapitalisasi pasar marang pendapatan QTTB|GOVX - Rasio rega marang pendapatan|Edesa Biotech Corp (EDSA) - Kapitalisasi marang pendapatan|IBIO: Multiplikator P/S|Carisma Therapeutics Inc. (CARM) - Multiplikator P/S|Kapitalisasi marang pendapatan XTLB|BOLT: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S HCWB|Koefisien rega marang pendapatan aptevotherapeutics.com|Rasio rega marang pendapatan AIM ImmunoTech Inc. AIM|ADTX - Kapitalisasi marang pendapatan|GRI - Rasio rega marang pendapatan|XORTX Therapeutics Inc (XRTX) - Kapitalisasi marang pendapatan|HIND (ReShape Lifesciences) - Kapitalisasi marang pendapatan|Revelation Biosciences Corp (REVB) - Multiplikator P/S|Rasio rega marang pendapatan Indaptus Therapeutics|Rasio kapitalisasi marang pendapatan SCNI (scinai.com)|Multiplikator P/S CALI|AFMD - Rega marang dodolan|Allakos - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan HOOK (HOOKIPA Pharma, Inc.)|IGM Bio - Multiplikator P/S|Rasio kapitalisasi pasar marang pendapatan ITOS (iteostherapeutics.com)|OCEA: Multiplikator P/S|Rega marang dodolan TC BioPharm (Holdings) Plc (TCBP)|Rasio rega marang pendapatan Third Harmonic Bio, Inc
